Neha Prakash, MD
Neurology · Farmington, CTNPI 1891135000
Payments from drug & device makers
What this record shows
Boston Scientific accounts for 92.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for neurology clinicians in CT, where the typical reported total is $893.
Across 7 payments — averaging $178.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Medtronic$88
Across 6 payments — averaging $41,313 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$248K
What the payments were for
- Travel & lodging$63251%
- Food & beverage$61549%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $1,159 |
| Medtronic | 1 | $88 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL DBS$958
- VERCISE$185
How this compares
$1,247 in reported general payments places this provider in the 50th percentile of 280 neurology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 24 | $123,297 |
| IngrezzaValbenazine Tosylate | 13 | $100,882 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 285 | $7,796 |
| Carbidopa | 20 | $4,326 |
| Ropinirole ErRopinirole Hcl | 22 | $3,308 |
| Propranolol Hcl ErPropranolol Hcl | 48 | $2,122 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 69 | $1,749 |
| AmantadineAmantadine Hcl | 22 | $1,510 |
| Donepezil Hcl | 114 | $1,474 |
| Trihexyphenidyl Hcl | 57 | $1,239 |
| Gabapentin | 57 | $1,228 |
| Midodrine Hcl | 21 | $965 |
| Memantine Hcl | 33 | $808 |
| Atropine Sulfate | 12 | $705 |
| Primidone | 29 | $532 |
Paid to pharmacies, not to this prescriber.
Other neurology in Farmington
- Wanda Castro-BorreroFarmington$553K
- Amanda Hernandez-JonesFarmington$303K
- Ashmanie MahatooFarmington$92K
- Jaime Imitola HerreraFarmington$53K
- Hamza CobanFarmington$17K
- Matthew ImperioliFarmington$13K
- Peter McAllisterFairfield$2.3M
- Stewart TepperStamford$1.2M
- Sharon StollNew Haven$822K
- Mary BaileyNew Haven$630K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.